<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="KO" article-type="case-report">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Korean Ophthalmol Soc</journal-id>
<journal-id journal-id-type="publisher-id">JKOS</journal-id>
<journal-title-group>
<journal-title>Journal of the Korean Ophthalmological Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0378-6471</issn>
<issn pub-type="epub">2092-9374</issn>
<publisher>
<publisher-name>The Korean Ophthalmological Society</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.3341/jkos.2020.61.3.307</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Regression of Neovascularization after Using Only Intraocular Pressure-lowering Medications in Neovascular Glaucoma</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sang Wook</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kim</surname>
<given-names>Ko Eun</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

</contrib-group>

<aff id="A1">Department of Ophthalmology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, <country>Korea</country>.</aff>

<author-notes>
<corresp>Address reprint requests to Ko Eun Kim, MD, PhD. Department of Ophthalmology, Nowon Eulji Medical Center, Eulji University School of Medicine, #68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, Korea. Tel: 82-2-970-8271, Fax: 82-2-970-8862, <email>csckek@gmail.com</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>61</volume>
<issue>3</issue>
<fpage>307</fpage>
<lpage>312</lpage>

<history>
<date date-type="received">
<day>20</day>
<month>06</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>08</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>02</month>
<year>2020</year>
</date>
</history>

<permissions>
<copyright-statement>&#x00A9;2020 The Korean Ophthalmological Society</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>The Korean Ophthalmological Society</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<sec>
<title>Purpose</title>
<p>To report a case of neovascular glaucoma after intraocular lens iris fixation, in which the neovascularization of the iris and the anterior chamber improved with only intraocular pressure (IOP) lowering agents, without treatment of the underlying cause.</p>
</sec>
<sec>
<title>Case summary</title>
<p>A 74-year-old woman who had undergone bilateral cataract surgery presented with left ocular pain and headache that started 3 days previously. At the initial examination, the best-corrected visual acuity was 0.9, and the IOP was 38 mmHg in the left eye. Slit-lamp examination of the left eye revealed diffuse iris neovascularization and several polypropylene suture knots fixated in the superior and inferior iris. Gonioscopic examination revealed angle neovascularization in all quadrants, with focal peripheral anterior synechia in the inferior quadrant. Fundus examination presented inferior neuroretinal rim thinning and an inferior retinal nerve fiber layer defect in the left eye. Fluorescent angiography showed no ischemic retinal lesions, with the exception of several retinal microaneurysms. Six months after topical IOP-lowering treatment in the left eye, the IOP was 10 mmHg, and neovascularization of the iris and angle had regressed completely.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>In the case of early-stage neovascular glaucoma with partial angle closure not associated with retinal ischemia, IOP-lowering treatment can be effective without other invasive procedures.</p>
</sec>
</abstract>

<kwd-group>
<kwd>Angle neovascularization</kwd>
<kwd>Intraocular lens fixation</kwd>
<kwd>Intraocular pressure-lowering medication</kwd>
<kwd>Iris neovascularization</kwd>
<kwd>Neovascular glaucoma</kwd>
</kwd-group>

</article-meta>
</front>

<back>

<fn-group>
<fn fn-type="conflict">
<label>Conflicts of Interest</label>
  <p>The authors have no conflicts to disclose.</p>
</fn>
</fn-group>

    <ref-list>

  <ref id="B1">
    <label>1</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Sivak-Callcott</surname>
          <given-names>JA</given-names>
        </name>
        <name>
          <surname>O'Day</surname>
          <given-names>DM</given-names>
        </name>
        <name>
          <surname>Gass</surname>
          <given-names>JD</given-names>
        </name>
        <name>
          <surname>Tsai</surname>
          <given-names>JC</given-names>
        </name>
      </person-group>
      <article-title>Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma</article-title>
      <source>Ophthalmology</source>
      <year>2001</year>
      <volume>108</volume>
      <fpage>1767</fpage>
      <lpage>1776</lpage>
    </element-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Shazly</surname>
          <given-names>TA</given-names>
        </name>
        <name>
          <surname>Latina</surname>
          <given-names>MA</given-names>
        </name>
      </person-group>
      <article-title>Neovascular glaucoma: etiology, diagnosis and prognosis</article-title>
      <source>Semin Ophthalmol</source>
      <year>2009</year>
      <volume>24</volume>
      <fpage>113</fpage>
      <lpage>121</lpage>
    </element-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Hayreh</surname>
          <given-names>SS</given-names>
        </name>
      </person-group>
      <article-title>Neovascular glaucoma</article-title>
      <source>Prog Retin Eye Res</source>
      <year>2007</year>
      <volume>26</volume>
      <fpage>470</fpage>
      <lpage>485</lpage>
    </element-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Jeong</surname>
          <given-names>YC</given-names>
        </name>
        <name>
          <surname>Hwang</surname>
          <given-names>YH</given-names>
        </name>
      </person-group>
      <article-title>Etiology and features of eyes with rubeosis iridis among Korean patients: A Population-Based Single Center Study</article-title>
      <source>PLoS One</source>
      <year>2016</year>
      <volume>11</volume>
      <elocation-id>e0160662</elocation-id>
    </element-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Cohen</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Kremer</surname>
          <given-names>I</given-names>
        </name>
        <name>
          <surname>Yassur</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Ben-Sira</surname>
          <given-names>I</given-names>
        </name>
      </person-group>
      <article-title>Peripheral retinal neovascularization and rubeosis iridis after a bilateral circular buckling operation</article-title>
      <source>Ann Ophthalmol</source>
      <year>1988</year>
      <volume>20</volume>
      <fpage>153</fpage>
      <lpage>156</lpage>
    </element-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Barile</surname>
          <given-names>GR</given-names>
        </name>
        <name>
          <surname>Chang</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Horowitz</surname>
          <given-names>JD</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery</article-title>
      <source>Am J Ophthalmol</source>
      <year>1998</year>
      <volume>126</volume>
      <fpage>379</fpage>
      <lpage>389</lpage>
    </element-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Aref</surname>
          <given-names>AA</given-names>
        </name>
      </person-group>
      <article-title>Current management of glaucoma and vascular occlusive disease</article-title>
      <source>Curr Opin Ophthalmol</source>
      <year>2016</year>
      <volume>27</volume>
      <fpage>140</fpage>
      <lpage>145</lpage>
    </element-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Wakabayashi</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Oshima</surname>
          <given-names>Y</given-names>
        </name>
        <name>
          <surname>Sakaguchi</surname>
          <given-names>H</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases</article-title>
      <source>Ophthalmology</source>
      <year>2008</year>
      <volume>115</volume>
      <fpage>1571</fpage>
      <lpage>1580</lpage>
      <fpage>80.e1</fpage>
      <lpage>80.e3</lpage>
    </element-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Wand</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Dueker</surname>
          <given-names>DK</given-names>
        </name>
        <name>
          <surname>Aiello</surname>
          <given-names>LM</given-names>
        </name>
        <name>
          <surname>Grant</surname>
          <given-names>WM</given-names>
        </name>
      </person-group>
      <article-title>Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma</article-title>
      <source>Am J Ophthalmol</source>
      <year>1978</year>
      <volume>86</volume>
      <fpage>332</fpage>
      <lpage>339</lpage>
    </element-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Iliev</surname>
          <given-names>ME</given-names>
        </name>
        <name>
          <surname>Domig</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Wolf-Schnurrbursch</surname>
          <given-names>U</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma</article-title>
      <source>Am J Ophthalmol</source>
      <year>2006</year>
      <volume>142</volume>
      <fpage>1054</fpage>
      <lpage>1056</lpage>
    </element-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Batman</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Ozdamar</surname>
          <given-names>Y</given-names>
        </name>
      </person-group>
      <article-title>The effect of bevacizumab for anterior segment neovascularization after silicone oil removal in eyes with previous vitreoretinal surgery</article-title>
      <source>Eye (Lond)</source>
      <year>2010</year>
      <volume>24</volume>
      <fpage>1243</fpage>
      <lpage>1246</lpage>
    </element-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Mason</surname>
          <given-names>JO</given-names>
          <suffix>3rd</suffix>
        </name>
        <name>
          <surname>Albert</surname>
          <given-names>MA</given-names>
          <suffix>Jr</suffix>
        </name>
        <name>
          <surname>Mays</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Vail</surname>
          <given-names>R</given-names>
        </name>
      </person-group>
      <article-title>Regression of neovascular iris vessels by intravitreal injection of bevacizumab</article-title>
      <source>Retina</source>
      <year>2006</year>
      <volume>26</volume>
      <fpage>839</fpage>
      <lpage>841</lpage>
    </element-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Costa</surname>
          <given-names>VP</given-names>
        </name>
        <name>
          <surname>Harris</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Anderson</surname>
          <given-names>D</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Ocular perfusion pressure in glaucoma</article-title>
      <source>Acta Ophthalmol</source>
      <year>2014</year>
      <volume>92</volume>
      <fpage>e252</fpage>
      <lpage>e266</lpage>
    </element-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Rolle</surname>
          <given-names>T</given-names>
        </name>
        <name>
          <surname>Tofani</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Brogliatti</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Grignolo</surname>
          <given-names>FM</given-names>
        </name>
      </person-group>
      <article-title>The effects of dorzolamide 2% and dorzolamide/timolol fixed combination on retinal and optic nerve head blood flow in primary open-angle glaucoma patients</article-title>
      <source>Eye (Lond)</source>
      <year>2008</year>
      <volume>22</volume>
      <fpage>1172</fpage>
      <lpage>1179</lpage>
    </element-citation>
  </ref>

  <ref id="B15">
    <label>15</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Siesky</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Harris</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Cantor</surname>
          <given-names>LB</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma</article-title>
      <source>Br J Ophthalmol</source>
      <year>2008</year>
      <volume>92</volume>
      <fpage>500</fpage>
      <lpage>504</lpage>
    </element-citation>
  </ref>

    </ref-list>

</back>

<floats-group>

<fig position="float" id="F1">
<label>Figure 1</label>
<caption>
  <title>Initial anterior segment photographs of the left eye. (A) Slit-lamp examination showing diffuse iris neovascularization. (B) Note two polypropylene suture knots in the inferior part and (C) one in the superior part accompanying iris neovascularization (arrows). (D) Gonioscopic examination showing neovascularization (arrow) in all quadrants and the representative picture is shown in the temporal quadrant.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkos-61-307-g001"></graphic>
</fig>

<fig position="float" id="F2">
<label>Figure 2</label>
<caption>
  <title>Initial examination of the patient. (A) Disc photograph showing an inferior neuroretinal rim thinning (arrow) and (B) red-free retinal nerve fiber layer (RNFL) photograph showing an inferior RNFL defect (arrowheads) in the left eye. Optical coherence tomography image presenting (C) inferior RNFL thinning and (D) corresponding retinal ganglion cell layer defect. (E) Fluorescein angiography image showing no definite ischemic retinal lesion, except several microaneurysms. NS = nasal-superior; TS = temporal-superior; T = temporal; TI = temporal-inferior; NI = nasal-inferior; G = global; N = nasal.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkos-61-307-g002"></graphic>
</fig>

<fig position="float" id="F3">
<label>Figure 3</label>
<caption>
  <title>Anterior segment photographs of the left eye at six months after topical intraocular pressure lowering treatment. (A) Slit-lamp examination showing complete regression of the iris neovascularization. (B, C) The remaining polypropylene suture knots fixated in the iris with the compete regression of iris neovascularization. (D) Gonioscopic examination also showing complete regression of angle neovascularization.</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkos-61-307-g003"></graphic>
</fig>

</floats-group>

</article>